Vivodyne Announces $38 Million Seed Financing Led By Khosla Ventures To Develop Lab-Grown Human Organs
Amount Raised
$38 Million
Round Type
Seed
BrisbaneInformation TechnologyBiotechnologyInvestors
Description
Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS Ventures, MBX Capital, and Bison Ventures.
Quick answer
Vivodyne raised $38 Million in a Seed round, dated November 22, 2023. Investors: Kairos Ventures, Cs Ventures, MBX Capital, Bison Ventures and Khosla Ventures. Vivodyne is based in Brisbane, California, United States.
- How much did Vivodyne raise?
- Vivodyne raised $38 Million in a Seed round on November 22, 2023.
- Who invested in Vivodyne?
- Kairos Ventures, Cs Ventures, MBX Capital, Bison Ventures and Khosla Ventures are named as investors in this round.
- What does Vivodyne do?
- Vivodyne is a biotechnology company that accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time.
- Where is Vivodyne based and how big is it?
- Vivodyne is based in Brisbane, California, United States. Fundz records about 38 employees.
- Who are the decision-makers at Vivodyne?
- Fundz holds 1 contact at Vivodyne. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Vivodyne that raised within 45 days of this round, from Fundz verified event records.
- Clarametyx Biosciences raised $33M (Series A) on January 5, 2024.
- Aether Therapeutics raised $4.1M (Seed) on January 5, 2024.
- Nabla raised $24M (Series B) on January 5, 2024.
- Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
- ViaLase raised $45M (Seed) on January 5, 2024.
- Montara Therapeutics raised $8M on January 5, 2024.
Who to call at Vivodyne, and when
A new round usually means Vivodyne is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vivodyne raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vivodyne, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vivodyne. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vivodyne raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vivodyne raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.